Diagonal Bio announces successful external validation of LAMPlify® for viruses in pigs
Diagonal Bio AB (publ) (“Diagonal” or “the Company”) announces successful results of a recent pilot study conducted by the Centre for Diagnostics at DTU Health Technology. The study evaluated the performance of the LAMPlify® assay panel for tests specific to Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) type 1 and type 2, and Swine Influenza Virus (SIV), by comparing it to the gold-standard PCR (qPCR) tests.The study showed excellent agreement between the LAMPlify® assays and qPCR tests, yielding identical positive/negative classifications between the methods. The samples were
Read original